215 related articles for article (PubMed ID: 34199217)
1. Severe Phenotype in Patients with Large Deletions of
Pacot L; Vidaud D; Sabbagh A; Laurendeau I; Briand-Suleau A; Coustier A; Maillard T; Barbance C; Morice-Picard F; Sigaudy S; Glazunova OO; Damaj L; Layet V; Quelin C; Gilbert-Dussardier B; Audic F; Dollfus H; Guerrot AM; Lespinasse J; Julia S; Vantyghem MC; Drouard M; Lackmy M; Leheup B; Alembik Y; Lemaire A; Nitschké P; Petit F; Dieux Coeslier A; Mutez E; Taieb A; Fradin M; Capri Y; Nasser H; Ruaud L; Dauriat B; Bourthoumieu S; Geneviève D; Audebert-Bellanger S; Nizon M; Stoeva R; Hickman G; Nicolas G; Mazereeuw-Hautier J; Jannic A; Ferkal S; Parfait B; Vidaud M; Members Of The Nf France Network ; Wolkenstein P; Pasmant E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34199217
[TBL] [Abstract][Full Text] [Related]
2. [Clinical diagnosis of neurofibromatosis type 1].
Wolkenstein P; Zeller J
Presse Med; 1999 Dec; 28(39):2174-80. PubMed ID: 10629698
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
4. NF1 microdeletion syndrome: case report of two new patients.
Serra G; Antona V; Corsello G; Zara F; Piro E; Falsaperla R
Ital J Pediatr; 2019 Nov; 45(1):138. PubMed ID: 31703719
[TBL] [Abstract][Full Text] [Related]
5. The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease.
Kehrer-Sawatzki H; Bäzner U; Krämer J; Lewerenz J; Pfeiffer C
J Dtsch Dermatol Ges; 2022 Mar; 20(3):273-277. PubMed ID: 35246941
[TBL] [Abstract][Full Text] [Related]
6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
8. NF1 frameshift mutation (c.6520_6523delGAGA) association with nervous system tumors and bone abnormalities in a Chinese patient with neurofibromatosis type 1.
Su SY; Zhou X; Pang XM; Chen CY; Li SH; Liu JL
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173220
[TBL] [Abstract][Full Text] [Related]
9. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
10. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
Colman SD; Williams CA; Wallace MR
Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
[TBL] [Abstract][Full Text] [Related]
11. Identification of large NF1 duplications reciprocal to NAHR-mediated type-1 NF1 deletions.
Kehrer-Sawatzki H; Bengesser K; Callens T; Mikhail F; Fu C; Hillmer M; Walker ME; Saal HM; Lacassie Y; Cooper DN; Messiaen L
Hum Mutat; 2014 Dec; 35(12):1469-75. PubMed ID: 25205021
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1: Expanded variant spectrum with multiplex ligation-dependent probe amplification and genotype-phenotype correlation in 138 Turkish patients.
Güneş N; Yeşil G; Geyik F; Kasap B; Celkan T; Kebudi R; Tüysüz B
Ann Hum Genet; 2021 Sep; 85(5):155-165. PubMed ID: 33877690
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.
Puglisi F; Soma R; Podda M; Vetrella S; Rabusin M; Tropia S; Meli M; Russo G; Sorrentino S; Erminio G; Pulvirenti A; Ruggieri M; Di Cataldo A
Front Pediatr; 2022; 10():950911. PubMed ID: 36405824
[TBL] [Abstract][Full Text] [Related]
14. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
Kehrer-Sawatzki H; Vogt J; Mußotter T; Kluwe L; Cooper DN; Mautner VF
Neurogenetics; 2012 Aug; 13(3):229-36. PubMed ID: 22581253
[TBL] [Abstract][Full Text] [Related]
17. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
18. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
19. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H; Mautner VF; Cooper DN
Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
[TBL] [Abstract][Full Text] [Related]
20. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
